Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Share-based Compensation (2016 - 2017)

Skinvisible's Share-based Compensation history spans 8 years, with the latest figure at $60456.0 for Q4 2017.

  • On a quarterly basis, Share-based Compensation rose 391.47% to $60456.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $223090.0, a 53.07% increase, with the full-year FY2017 number at $223090.0, up 53.07% from a year prior.
  • Share-based Compensation hit $60456.0 in Q4 2017 for Skinvisible, up from $47302.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for SKVI hit a ceiling of $133445.0 in Q1 2016 and a floor of $3000.0 in Q2 2013.
  • Historically, Share-based Compensation has averaged $34898.9 across 5 years, with a median of $23400.0 in 2014.
  • Biggest five-year swings in Share-based Compensation: soared 1416.42% in 2016 and later crashed 82.02% in 2017.
  • Tracing SKVI's Share-based Compensation over 5 years: stood at $8400.0 in 2013, then skyrocketed by 178.57% to $23400.0 in 2014, then plummeted by 78.63% to $5000.0 in 2015, then surged by 146.02% to $12301.0 in 2016, then soared by 391.47% to $60456.0 in 2017.
  • Business Quant data shows Share-based Compensation for SKVI at $60456.0 in Q4 2017, $47302.0 in Q3 2017, and $91332.0 in Q2 2017.